⚠️
This device has not received regulatory clearance
This listing is based on publicly available information and has not been verified by the manufacturer or any regulatory authority.
ALT-006190Pre-approval
Unnamed AI-enabled technology
University of California, San Francisco · Sponsor
Named product not publicly identified
Regulatory Pipeline
✓
Proof of Concept✓
Development3
Clinical Trial4
Pre-submission5
Submitted6
Under Review7
ClearedAll identifiers (2)
Aletia (canonical)
ALT-006190ClinicalTrials.gov (primary)
NCT05303051Trial signal only — manufacturer hasn't claimed this listing yet.
The trial data below was imported from ClinicalTrials.gov. If you represent University of California, San Francisco, you can claim this listing to add funding, team, and contact details.
Claim this listing →Clinical Trial Signal
NCT05303051 ↗
terminated
Validation of the Diabetes Deep Neural Network Score for Diabetes Mellitus Screening
Phase: na0 enrolledUS
Investor Interest
Signal to the team that this device is on your radar. Anonymous — the manufacturer sees the count, not your identity.
0
investors